A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Gastrointestinal DiscomfortPerformance Status
- Interventions
- Dietary Supplement: G3P-01
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05296083
- Locations
- 🇳🇱
EB FlevoResearch, Almere, Flevoland, Netherlands
A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure
Phase 1
Completed
- Conditions
- Heart Failure
- Interventions
- Combination Product: SQIN-01
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2021-11-26
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04846816
- Locations
- 🇬🇧
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device)
Not Applicable
Completed
- Conditions
- Healthy Volunteer Study
- Interventions
- Other: 3M 1529 Adhesive Tape
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04836572
- Locations
- 🇺🇸
Community Clinical Research Network, Marlborough, Massachusetts, United States
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
Phase 1
Completed
- Conditions
- Heart Failure
- Interventions
- Device: Medfusion 3500 (v6) precision infusion pump
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04384653
- Locations
- 🇺🇸
Accel Research Sites - DeLand Clinical Research Unit, DeLand, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath